ESET Foundation: Scientists from Slovakia's MultiplexDX, Lambda Life and ProScience Tech joined forces with virologists from the Biomedical Research Center of the Slovak Academy of Sciences BMC SAV to develop reagents based on World Health Organization (WHO) protocols .) for the reliable detection of the SARS-CoV-2 virus.
In the first phase, they plan to produce and make available 100.000 diagnostics sets which the ESET Foundation will finance and offer to the Slovak government.
Crucial to the project is the contribution of MultiplexDX, a company that specializes in the development and manufacture of innovative molecular diagnostic reagents. At the present stage, the Slovak PCR test is being tested in collaboration with a team of scientists from BMC SAV.
According to the preliminary results, the new diagnostic test works satisfactorily and shows good sensitivity compared to the available diagnostic methods.
"This means that the diagnostic test we are preparing is reliable and accurate and can help diagnose her diseaseat an early stage. We can develop within two weeks what is required to produce 100.000 diagnostic tests," said Pavol Čekan, founder of MultiplexDX.
"For the process of evaluating and reporting the results of the research, we work with the non-profit organization CCCT SK. According to estimates, this stage will take about three weeks, "said Adam Andráško of ProScience Tech.
"Virus detection includes sampling, RNA isolation and PCR diagnosis, with the joint effort to focus on the final stage," said Ivan Juráš of Lambda Life
The entirety of it production, including the first 100.000 diagnostic kits, will initially be made available to diagnostic laboratories in Slovakia.
"We are ready to cooperate with state laboratories, responding immediately to their needs and supplying them with sufficient quantities. After satisfying the needs of the Slovak laboratories, we will be able to make available quantities to other countries that may need the productours" explain the creators of the test.
